Clinical trial
Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
NCT00274014 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274014 |
|---|---|
| Title | Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders |
| Official title | Effects of Inhaled Tiotropium Bromide on Severity of Airflow Obstruction During Long-term Treatment in Patients With Moderately Severe Copd. Impact on Severity and Incidence of Exacerbations. |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Tiotropium |
| Enrollment | 1,000 |
| Start date | Oct 1, 2000 |
| Primary completion | Oct 1, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Jan 10, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: